Cargando…

Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach

The COVID-19 pandemic is an unprecedented threat to humanity that has provoked global health concerns. Since the etiopathogenesis of this illness is not fully characterized, the prognostic factors enabling treatment decisions have not been well documented. Accurately predicting the progression of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimura, Yayoi, Nakai, Yusuke, Shin, Jihye, Hara, Miyui, Takeda, Yuriko, Kubo, Sousuke, Jeremiah, Sundararaj Stanleyraj, Ino, Yoko, Akiyama, Tomoko, Moriyama, Kayano, Sakai, Kazuya, Saji, Ryo, Nishii, Mototsugu, Kitamura, Hideya, Murohashi, Kota, Yamamoto, Kouji, Kaneko, Takeshi, Takeuchi, Ichiro, Hagiwara, Eri, Ogura, Takashi, Hasegawa, Hideki, Tamura, Tomohiko, Yamanaka, Takeharu, Ryo, Akihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526747/ https://www.ncbi.nlm.nih.gov/pubmed/34667241 http://dx.doi.org/10.1038/s41598-021-98253-9

Ejemplares similares

Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies
por: Kubo, Sousuke, et al.
Publicado: (2021)

Phosphopeptide enrichment using Phos-tag technology reveals functional phosphorylation of the nucleocapsid protein of SARS-CoV-2
por: Ino, Yoko, et al.
Publicado: (2022)

Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2022)

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
por: Miyakawa, Kei, et al.
Publicado: (2020)

Identification of mouse soleus muscle proteins altered in response to changes in gravity loading
por: Ino, Yoko, et al.
Publicado: (2023)

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
por: Miyakawa, Kei, et al.
Publicado: (2021)

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2
por: Miyakawa, Kei, et al.
Publicado: (2022)

Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2021)

Characterization and Utilization of Disulfide-Bonded SARS-CoV-2 Receptor Binding Domain of Spike Protein Synthesized by Wheat Germ Cell-Free Production System
por: Yamaoka, Yutaro, et al.
Publicado: (2022)

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection
por: Miyakawa, Kei, et al.
Publicado: (2021)

Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors
por: Goto, Atsushi, et al.
Publicado: (2021)

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
por: Morita, Takeshi, et al.
Publicado: (2021)

Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy
por: Hatayama, Yasuyoshi, et al.
Publicado: (2022)

Severe multivessel coronary vasospasm in a patient with coronavirus disease 2019
por: Azuma, Mai, et al.
Publicado: (2023)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

Development of Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of Human Norovirus Major Capsid Protein
por: Kimura, Yayoi, et al.
Publicado: (2022)

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor
por: Funabashi, Rikako, et al.
Publicado: (2021)

Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19
por: Saji, Ryo, et al.
Publicado: (2021)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
por: Okuda, Ryo, et al.
Publicado: (2023)

Clinical characteristics of Japanese patients with moderate to severe COVID-19
por: Otoshi, Ryota, et al.
Publicado: (2021)

Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019
por: Yamaya, Takafumi, et al.
Publicado: (2021)

Pulmonary vascular enlargement and lesion extent on computed tomography are correlated with COVID-19 disease severity
por: Aoki, Ryo, et al.
Publicado: (2021)

Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases
por: Murohashi, Kota, et al.
Publicado: (2020)

Pneumothorax in a COVID-19 Pneumonia Patient without Underlying Risk Factors
por: Yamaya, Takafumi, et al.
Publicado: (2020)

Imaging of COVID-19: An update of current evidences
por: Kato, Shingo, et al.
Publicado: (2021)

Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase
por: Okuda, Ryo, et al.
Publicado: (2022)

Serum cholinesterase associated with COVID-19 pneumonia severity and mortality
por: Nakajima, Kento, et al.
Publicado: (2021)

Generation and Utilization of a Monoclonal Antibody against Hepatitis B Virus Core Protein for a Comprehensive Interactome Analysis
por: Nakai, Yusuke, et al.
Publicado: (2022)

Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19
por: Nagasawa, Ryo, et al.
Publicado: (2023)

Prostaglandin-E2 receptor-4 stimulant rescues cardiac malfunction during myocarditis and protects the heart from adverse ventricular remodeling after myocarditis
por: Takakuma, Akira, et al.
Publicado: (2021)

Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
por: Sekine, Akimasa, et al.
Publicado: (2022)

Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19
por: Ogawa, Fumihiro, et al.
Publicado: (2021)

Editorial for the Special Issue: Molecular Epidemiology, Diagnostics and Management of Respiratory Virus Infections
por: Kimura, Hirokazu, et al.
Publicado: (2020)

Pilot Quasi-Randomized Controlled Study of Herbal Medicine Hochuekkito as an Adjunct to Conventional Treatment for Progressed Pulmonary Mycobacterium avium Complex Disease
por: Enomoto, Yasunori, et al.
Publicado: (2014)

Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer
por: Okabayashi, Hiroko, et al.
Publicado: (2021)

Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in transbronchial lung cryobiopsy
por: Okabayashi, Hiroko, et al.
Publicado: (2020)

Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests
por: Yamaoka, Yutaro, et al.
Publicado: (2021)

In reply
por: Iwasawa, Tae, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3408tavmas4n44usjradgl7uvi